At the same time, MSC-Exo treatment increased the expression of pyruvate dehydrogenase (PDH) and glutamate dehydrogenase 1 (GLUD1) in pulmonary artery smooth muscle cells, providing evidence for the improvement of mitochondrial function in PAH patients (139). The gene discussed is GLUD1; the disease is pulmonary arterial hypertension.